Clinical Trial Update: Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial assesses neoadjuvant chemotherapy with or without Apatinib for HER2-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: RenJi Hospital | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING